Cited by — Systemic inflammation and prognosis in patients with RAS / BRAF wild‐type metastatic colorectal cancer receiving anti‐ EGFR therapy: A real‐world cohort study | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Systemic inflammation and prognosis in patients with RAS / BRAF wild‐type metastatic colorectal cancer receiving anti‐ EGFR therapy: A real‐world cohort study.
No admitted local citation edges point to this work yet.
